Skip to main content

Regulatory Information Management Systems, as a Means for Ensuring the Pharmaceutical Data Continuity and Risk Management

  • Conference paper
  • First Online:
Intelligent Decision Technologies 2019

Abstract

Possibilities of regulatory information management systems implementation together with other technological solutions to ensure data continuity and integrity as a prerequisite for the implementation of a risk management system in pharmaceutical data management are discussed in this article. The creation of an effective information generation process at the lifecycle stages of the pharmaceutical product is described. Regarding the needs of initial creation and making changes to the registration documentation or the implementation of pharmacovigilance, it is also necessary to ensure the continuity and integrity of information relating to such a critical component of the public health system as medicines. Major functions of regulatory information management systems are listed in coordinance with electronic data capture necessities in clinical trials and further pharmaceutical product dossier creation. Also, the reasons for integration with electronic medical records are presented. On the side of essential data infrastructure creation, major key points are listed, such as virtual servers, disk arrays, and replication technologies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Herper M.: The truly staggering cost of inventing new drugs. Forbes homepage. https://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/. Last accessed 12 July 2018

  2. The pharmaceutical industry in figures. EFPIA homepage. https://www.efpia.eu/media/25055/the-pharmaceutical-industry-in-figures-june-2016.pdf. Last accessed 12 July 2018

  3. Biopharmaceutical R&D Statistical Sourcebook Parexel 2016/2017. Barnett International (2017)

    Google Scholar 

  4. Biopharmaceutical Research Industry. PhRMA homepage. http://www.phrma.org/report/industry-profile-2016. Last accessed 19 Nov 2018

  5. Urquhart C., Hamad F., Tbaishat D., Yeoman A.: Chapter 13: health information systems: clinical data capture and document architecture. In: Information Systems: Process and Practice, pp. 233–253 (2017)

    Google Scholar 

  6. Guidance for Industry Electronic Source Data in Clinical Investigations. U.S. Department of Health and Human Services Food and Drug Administration homepage. https://www.fda.gov/downloads/drugs/guidances/ucm328691.pdf. Last accessed 23 Sept 2018

  7. Regulatory Information Management Software Solutions. The EXTEDO suite—homepage. https://www.extedo.com/products/product-overview/extedosuite/. . Last accessed 23 Dec 2018

  8. Koshechkin K.A.: Experience in creating an information system for managing the testing laboratories of an expert institution in the field of drug circulation. In: Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products, No. 2, pp. 103–108 (2018)

    Google Scholar 

  9. Regulatory Information Management. Parexel homepage. https://www.parexel.com/solutions/informatics/regulatory-clinical-technology/regulatory-information-management. Last accessed 23 Dec 2018

  10. Upton J.: Regulatory Information Management: Current and the Future States. Pharm exec homepage. http://www.pharmexec.com/regulatory-information-management-current-and-future-states. Last accessed 23 Dec 2018

  11. LekSoft-Online Registration homepage. http://www.leksoft.ru/Files/leksoft-regls-promo-2018.pdf. Last accessed 23 Dec 2018

  12. Data Continuity—The True Essence of Disaster Recovery. Stonefly homepage. https://stonefly.com/resources/data-continuity-the-true-essence-of-disaster-recovery. Last accessed 12 July 2018

  13. Risk management in the pharmaceuticals and life sciences industry. The Economist homepage. https://eiuperspectives.economist.com/sites/default/files/Risk%20management%20in%20the%20pharmaceuticals%20and%20life%20sciences%20industry.pdf. Last accessed 12 July 2018

  14. Dhankhar A., Ganguly S., Govindarajan A., Thun M.: Expanding horizons for risk management in pharma. Mckinsey homepage. https://www.mckinsey.com/business-functions/risk/our-insights/expanding-horizons-for-risk-management-in-pharma. Last accessed 12 Jan 2019

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konstantin Koshechkin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Koshechkin, K., Lebedev, G., Tikhonova, J. (2020). Regulatory Information Management Systems, as a Means for Ensuring the Pharmaceutical Data Continuity and Risk Management. In: Czarnowski, I., Howlett, R., Jain, L. (eds) Intelligent Decision Technologies 2019. Smart Innovation, Systems and Technologies, vol 142. Springer, Singapore. https://doi.org/10.1007/978-981-13-8311-3_23

Download citation

Publish with us

Policies and ethics